Form D — Aspicio Therapeutics, Inc.

0002025735-26-000001 · filed Jul 17, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Other Health Care filings

Offering

Industry: Other Health Care
Exemptions: 06b
Reported offering amount: $200,000
Reported amount sold: $200,000
Minimum investment: $0
Investors: 2
Sales commission: $0
Finders' fees: $0

Issuer

Name: Aspicio Therapeutics, Inc.
CIK: 2025735
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2024
Address: 250 TRUMAN WAY
DOWNINGTOWN, PA 19335
Phone: 484.885.4744

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Michael Keane · Executive Officer

Downingtown, PA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗